Table 2.

Comparing self-reported local and systematic adverse events related to SARS-CoV-2 vaccination among People living with HIV (PLWH) and HIV-negative individuals.

	People Living with HIV (n = 129)	HIV-Negative Individuals (n = 53)	p Values
	n (%)	n (%)
Local Adverse Events
Pain
None	87 (67.4)	31 (58.5)
Very mild	15 (11.6)	4 (7.5)
Mild	16 (12.4)	11 (20.8)
Moderate	11 (8.5)	7 (13.2)
Severe	0 (0.0)	0 (0.0)	0.30
Any of above	42 (32.6)	22 (41.5)	0.25
Redness, itch, swelling, induration, and/or skin rash
None	124 (96.1)	50 (94.3)
Very mild	0 (0.0)	1 (1.9)
Mild	2 (1.6)	2 (3.8)
Moderate	3 (2.3)	0 (0.0)
Severe	0 (0.0)	0 (0.0)	0.21
Any of above	5 (3.9)	3 (5.7)	0.59
Systematic adverse events
Fatigue, malaise, headache, dizziness, and/or lethargy
None	107 (82.9)	43 (81.1)
Very mild	5 (3.9)	3 (5.7)
Mild	11 (8.5)	4 (7.5)
Moderate	5 (3.9)	2 (3.8)
Severe	1 (0.8)	1 (1.9)	0.94
Any of above	22 (17.1)	10 (18.9)	0.77
Joint pain and/or muscle ache
None	119 (92.2)	45 (84.9)
Very mild	4 (3.1)	1 (1.9)
Mild	3 (2.3)	4 (7.5)
Moderate	3 (2.3)	3 (5.7)
Severe	0 (0.0)	0 (0.0)	0.23
Any of above	10 (7.8)	8 (15.1)	0.13
Fever
None	122 (94.6)	52 (98.1)
Very mild	2 (1.6)	0 (0.0)
Mild	4 (3.1)	1 (1.9)
Moderate	1 (0.8)	0 (0.0)
Severe	0 (0.0)	0 (0.0)	0.69
Any of above	7 (5.4)	1 (1.9)	0.27
Nausea, vomit, and/or diarrhea
None	129 (100.0)	52 (98.1)
Very mild	0 (0.0)	0 (0.0)
Mild	0 (0.0)	1 (1.9)
Moderate	0 (0.0)	0 (0.0)
Severe	0 (0.0)	0 (0.0)	0.12
Any of above	0 (0.0)	1 (1.9)	0.29
Other systematic side-effects
None	127 (98.4)	53 (100.0)
Very mild	2 (1.6)	0 (0.0)
Mild	0 (0.0)	0 (0.0)
Moderate	0 (0.0)	0 (0.0)
Severe	0 (0.0)	0 (0.0)	0.36
Any of above	2 (1.6)	0 (0.0)	0.50
Any local and/or systematic adverse events	58 (45.0)	29 (54.7)	0.23